INSM
INSM
NASDAQ · Biotechnology

Insmed Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$98.61
+2.81 (+2.93%)
As of Jun 22, 9:36 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 28 97%
Hold 1 3%
Sell 0 0%
Price Target
Analyst Price Target +45.4% upside
Low Target $91.17
Average Target $143.40
High Target $177.14
Current Price $98.61
Current
$98.61
Target
$143.40
$91.17 $143.40 avg $177.14
Scenario Analysis
Bear Case
$91.17
-7.5%
Low target
Base Case
$143.40
+45.4%
Avg target
Bull Case
$177.14
+79.6%
High target
Risk/Reward
10.6x
Highly favorable
Price in Context
52-Week High
$212.75
-53.7% from high
52-Week Low
$90.39
+9.1% from low
50-Day SMA
$168.11
-41.3% vs SMA
200-Day SMA
$139.54
-29.3% vs SMA
RSI (14)
54.8
Neutral
Target vs 52W High
$143.40
-32.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%